// Biotech and Pharma Therapeutics Regeneron faces new biosimilar threats; an AI biotech lays off staff May 22, 2024 / Regeneron Biosimilars / Boehringer Ingelheim / OSE Deal / GSK Regeneron faces new competition from FDA-approved biosimilars for Eylea. Boehringer...